Bedfordshire and Luton Joint Prescribing Committee
Ref: JPC Bulletin 295
Bulletin Date: 26/01/21
Review Date: Dec 2023
NHS England: Statin Intolerance Pathway and Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD
NHS England and the Accelerated Access Collaborative have produced the following:-
- Pathway for the management of Statin Intolerance for patients with CVD risk
- Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD.
The pathway and guidance promotes the use of higher intensity statins such as atorvastatin and rosuvastatin in preference to lower intensity statins such as pravastatin and fluvastatin.
Click here to access the pathway.
Click here to access the summary
Both the pathway and guidance have been endorsed by NICE and endorsed locally by the JPC (Dec 2020).